1 / 1

Synergistic Combination of ITF2357 and Pemetrexed Enhances Viability in Lung Cancer Cells

Explore the effects of ITF2357 and Pemetrexed combination on lung cancer cell viability. Analyze dose response, combination index, and fraction affected in A549, H1299, and Calu-1 cells.

flavia-estes
Download Presentation

Synergistic Combination of ITF2357 and Pemetrexed Enhances Viability in Lung Cancer Cells

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure S1 ITF2357 Pem Combination A A549 H1299 Calu-1 ITF2357+Pem Viability (%) ITF2357->Pem Doses (µM) B Calu-1 A549 H1299 ITF2357+Pem CombinationIndex ITF2357->Pem Fractionedaffected

More Related